Loading data
CLGNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.37 m USD | 515 k USD | 10.96 m USD | 299 k USD | 15.64 m USD |
| Cost of revenue | 835 k USD | 1.63 m USD | 1.99 m USD | 400 k USD | 2.01 m USD |
| Gross profit | 1.54 m USD | -1.11 m USD | 8.97 m USD | -101 k USD | 13.64 m USD |
| Research and development expense | 8.19 m USD | 10.52 m USD | 10.48 m USD | 10.26 m USD | 7.63 m USD |
| Operating profit | -11.48 m USD | -17.25 m USD | -7.51 m USD | -17.1 m USD | 65 k USD |
| Income tax expense | — | 45.99 m USD | 59.99 m USD | — | — |
| Net income (reported basis) | -11.49 m USD | -16.61 m USD | -7.02 m USD | -16.93 m USD | 237 k USD |
| Basic earnings per share | -0.94 USD/share | -1.45 USD/share | -0.62 USD/share | -1.53 USD/share | 0.02 USD/share |
| Diluted earnings per share | -0.94 USD/share | -1.45 USD/share | -0.62 USD/share | -1.53 USD/share | 0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.